Literature DB >> 27288429

Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis.

Matko Marlais1, Oliver Cuthell2, Dean Langan1, Jan Dudley2, Manish D Sinha3, Paul J D Winyard1.   

Abstract

CONTEXT: Autosomal dominant polycystic kidney disease (ADPKD) is a common disorder that can cause hypertension during childhood, but the true prevalence of hypertension during childhood is not known.
OBJECTIVE: We undertook a systematic review and meta-analysis to determine the prevalence of hypertension in children with ADPKD. DATA SOURCES: Systematic review of articles published between 1980 and 2015 in MEDLINE and EMBASE. STUDY SELECTION: Studies selected by two authors independently if reporting data on prevalence of hypertension in children and young persons aged <21 years with a diagnosis of ADPKD. Observational series were included with study populations of >15 children. Articles were excluded if inadequate diagnostic criteria for hypertension were used. Studies with selection bias were included but analysed separately. DATA EXTRACTION: Data extracted on prevalence of hypertension, proteinuria and reduced renal function using standardised form. Meta-analysis was performed to calculate weighted mean prevalence.
RESULTS: 903 articles were retrieved from our search; 14 studies met the inclusion criteria: 1 prospective randomised controlled trial; 8 prospective observational studies; and 5 retrospective cross-sectional studies. From 928 children with clinically confirmed ADPKD, 20% (95% CI 15% to 27%) were hypertensive. The estimated prevalence of proteinuria in children with ADPKD is 20% (8 studies; 95% CI 9% to 40%) while reduced renal function occurred in 8% (5 studies; 95% CI 2% to 26%). LIMITATIONS: Studies showed a high degree of methodological heterogeneity (I2=73.4%, τ2=0.3408, p<0.0001). Most studies did not use ambulatory blood pressure (BP) monitoring to diagnose hypertension.
CONCLUSIONS: In this meta-analysis we estimate 20% of children with ADPKD have hypertension. In the population, many children with ADPKD are not under regular follow-up and remain undiagnosed. We recommend that all children at risk of ADPKD have regular BP measurement. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Nephrology; Paediatric Practice

Mesh:

Year:  2016        PMID: 27288429     DOI: 10.1136/archdischild-2015-310221

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  22 in total

Review 1.  Polycystic kidney disease.

Authors:  Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres
Journal:  Nat Rev Dis Primers       Date:  2018-12-06       Impact factor: 52.329

2.  Prevalence of cardiac valvar abnormalities in children and young people with autosomal dominant polycystic kidney disease.

Authors:  Alexandra Savis; John M Simpson; Saleha Kabir; Kelly Peacock; Hayley Beardsley; Manish D Sinha
Journal:  Pediatr Nephrol       Date:  2022-06-28       Impact factor: 3.714

Review 3.  [What is evidence-based in the treatment of autosomal dominant polycystic kidney disease?]

Authors:  Vera Christine Wulfmeyer; Roland Schmitt
Journal:  Internist (Berl)       Date:  2021-10-28       Impact factor: 0.743

Review 4.  Is autosomal dominant polycystic kidney disease an early sweet disease?

Authors:  Angélique Dachy; Jean-Paul Decuypere; Rudi Vennekens; François Jouret; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2022-01-05       Impact factor: 3.651

5.  Imaging of Kidney Cysts and Cystic Kidney Diseases in Children: An International Working Group Consensus Statement.

Authors:  Charlotte Gimpel; E Fred Avni; Luc Breysem; Kathrin Burgmaier; Anna Caroli; Metin Cetiner; Dieter Haffner; Erum A Hartung; Doris Franke; Jens König; Max C Liebau; Djalila Mekahli; Albert C M Ong; Lars Pape; Andrea Titieni; Roser Torra; Paul J D Winyard; Franz Schaefer
Journal:  Radiology       Date:  2019-01-01       Impact factor: 11.105

6.  Demographic and clinical characteristics of children with autosomal dominant polycystic kidney disease: a single center experience

Authors:  Belde Kasap Demir; Fatma Mutlubaş; Eren Soyaltın; Caner Alparslan; Merve Arya; Demet Alaygut; Seçil Arslansoyu Çamlar; Afig Berdeli; Önder Yavaşcan
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

Review 7.  Tolvaptan in Pediatric Autosomal Dominant Polycystic Kidney Disease: From Here to Where?

Authors:  Fei Liu; Chunyue Feng; Huijun Shen; Huaidong Fu; Jianhua Mao
Journal:  Kidney Dis (Basel)       Date:  2021-07-02

Review 8.  Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?

Authors:  Stéphanie De Rechter; Luc Breysem; Djalila Mekahli
Journal:  Front Pediatr       Date:  2017-12-20       Impact factor: 3.418

9.  Is It Ethical to Test Apparently "Healthy" Children for Autosomal Dominant Polycystic Kidney Disease and Risk Medicalizing Thousands?

Authors:  Tess Harris
Journal:  Front Pediatr       Date:  2018-01-19       Impact factor: 3.418

Review 10.  Clinical Trials in Pediatric Autosomal Dominant Polycystic Kidney Disease.

Authors:  Melissa A Cadnapaphornchai
Journal:  Front Pediatr       Date:  2017-03-23       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.